Author: Jasenosky, Luke D.; Cadena, Cristhian; Mire, Chad E.; Borisevich, Viktoriya; Haridas, Viraga; Ranjbar, Shahin; Nambu, Aya; Bavari, Sina; Soloveva, Veronica; Sadukhan, Supriya; Cassell, Gail H.; Geisbert, Thomas W.; Hur, Sun; Goldfeld, Anne E.
Title: The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus Document date: 2019_8_8
ID: yomg30hg_48
Snippet: NTZ inhibition of live EBOV infection in A549 cells and CRISPR/dCas9-KRAB-based knock down of gene expression in A549 cells.....
Document: NTZ inhibition of live EBOV infection in A549 cells and CRISPR/dCas9-KRAB-based knock down of gene expression in A549 cells
Search related documents:
Co phrase search for related documents- ebov infection and NTZ inhibition: 1
Co phrase search for related documents, hyperlinks ordered by date